(5) The combination treatment of EGCG with sunitinib significantly decreased the frequency of CD4+, CD25+, CD127low, FOXP3+, Treg in the PBMC of the ccRCC patients compared to the group without treatment. The gene discussed is FOXP3; the disease is nonpapillary renal cell carcinoma.